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Understanding the ways in which gender impacts 
on chronic health conditions will be enhanced by 
explicitly mainstreaming gender … it is vital to 
infuse gender analysis, gender sensitive research, 
women’s perspectives and gender equity goals into 
policies, projects and institutional ways of working.
(AWHN 2012 p 5).
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Executive summary
Non-communicable diseases (cancer, cardiovascular 
disease, diabetes, chronic respiratory conditions, and 
musculo-skeletal conditions) are the number one cause 
of death and disablement for women and men globally 
and in Australia, with increasing recognition that 
women and men experience those conditions differently. 
This position paper examines the gender dimensions 
of those diseases to raise awareness, and to inform 
prevention and treatment guidelines. Building on the 
inequities for women documented in the AWHN 
Position Paper on Women’s Health and Wellbeing, 
this paper highlights the specific areas where gender 
blindness is occurring and the areas where change 
is needed. 
Despite the prevalence of Non-communicable diseases 
(NCDs) among women, there has been little emphases 
and even less action, on the differences that women 
experience in these diseases. Most guidelines and 
policies on NCDs are gender neutral. This has meant 
that women with non-communicable diseases have 
not received the level of support and services needed 
to ensure the best possible outcomes or that necessary 
research and education into gender differences has 
been funded. 
The lack of research into gender differences and the 
consequent lack of education for health providers 
and the population generally, potentially promotes 
poorer outcomes for women and increases gender 
inequities. When there is mounting evidence that 
women’s experience of NCDs is different to that of 
men’s experience, the gender neutrality of policies, 
research and education programs contributes to 
gender inequities. 
The impact of NCDs on women’s lives, the differences 
in risk factors for women than for men and the social 
determinants of NCDs are highlighted. Specific risks 
include, that:
•• Lung cancer is responsible for more women’s deaths 
than breast cancer although more women are 
diagnosed with breast cancer than lung cancer
•• Mortality rates from lung cancer in women are 
continuing to rise while they have plateaued or 
are dropping among men
•• Chronic Obstructive Pulmonary Disease (COPD) 
occurs at lower levels of exposure to tobacco smoking 
in women than men
•• women with diabetes have a higher risk of stroke 
than their male counterparts
•• women with diabetes have poorer survival after 
stroke than men. 
This paper also highlights the low rate of women in 
research trials and the low levels of reporting of sex-
disaggregated findings. These indicate that treatment 
recommendations are more generalisable for males than 
females and the research benefits are therefore greater 
for men. In turn, this accords a lower status in research 
to women’s health.
Failure to act on gender differences in non-
communicable disease costs lives. It is no longer 
satisfactory for prevention and treatment guidelines to 
remain gender neutral. Leadership from governments 
and peak health bodies is required to drive change in 
both policy and research. Understanding the ways in 
which gender interacts with NCDs will be enhanced 
by explicitly mainstreaming gender in policy, research, 
treatment guidelines and professional and public 
education. This paper recommends actions that can be 
taken to redress these problems, and achieve gender 
aware, gender sensitive and gender transformative care 
for women. 
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To improve the prevention, diagnosis and treatment 
of non-communicable disease (chronic conditions) for 
women AWHN recommends:
1. The National Health and Medical Research 
Council issue a guideline for the equal inclusion of 
women and the evaluation of gender differences in 
clinical trials to ensure that the safety and efficacy 
of therapies are adequately investigated in the full 
range of patients who would use the therapy.
2. Continued research through for example, the Heart 
Foundation and Diabetes Australia which fund 
research programs, is needed to explore the causes 
of the sex difference in non-communicable diseases 
(NCDs) in women in order to establish the evidence 
base about women’s experiences and symptom 
patterns as well as treatments to improve health care 
for women (Peters 2014). This evidence will inform 
the development of gender-informed guidelines on 
primary and secondary prevention of NCDs. For 
example, Pilote (2007) has put forward research 
questions which require attention:
•• Why is the risk of death for women with diabetes 
greater than it is for men with diabetes (Pilote 
2007)?
•• Why are women with atrial fibrillation at greater 
risk of stroke than men with atrial fibrillation 
(Pilote 2007)?
•• Why do women present with different coronary 
symptoms than men (Pilote 2007).
3. Peak health bodies which are funded to develop 
clinical guidelines for NCDs have a responsibility 
to move beyond the gender neutrality position they 
have adopted and address the gender differences 
in health experiences, treatment, drug efficacy and 
health outcomes. The knowledge that women with 
diabetes have a higher risk of cardiovascular disease 
(CVD), particularly stroke, should be built into 
clinical guidelines immediately. 
4. The Federal Government ensures that peak bodies 
develop gender sensitive guidelines and makes this 
a condition of funding of peak bodies. Guidelines 
are necessary to assist clinicians (medical and 
allied health) to assess risk and recognise gender 
differences (Betihavas, Davidson, Newton et al 
2012). Gender training based on guidelines are 
needed in speciality training of medical doctors to 
equip them with the skills needed for effective care 
of women and men, and to enhance their health 
literacy about gender differences. When counselling 
their clients clinicians need to ensure that both men 
and women have the help they need to successfully 
manage their NCDs (Wong, Gucciardi, Grace 2005, 
Yeats 2010). 
5. Federal, State and Territory Governments rewrite all 
current gender neutral policies so that they identify 
gender differences and what needs to happen for 
gender equity to be achieved. This will demonstrate 
good stewardship, improve the visibility of gender 
differences in policy documents about NCDs and 
achieve better health outcomes for women.
6. Provision of integrated women’s health services 
which are comprehensive, holistic and incorporate a 
life-span gender- sensitive approach would overcome 
the current fragmented approach to primary and 
secondary prevention for women with, or at higher 
risk of, NCD’s. Prioritising action on this should be 
taken in population health planning.
7. Federal Government funding is allocated through 
the primary care sector to develop gender-specific 
screening for pre-diabetes in women and increase 
screening coverage of women for diabetes to improve 
the effectiveness of the prevention of CVD events 
including stroke.
8. Diabetes peak bodies and the primary health care 
research and development program (i.e. Primary 
Health Care Research & Information Service and 
Australian Primary Health Care Research Institute) 
develop gender-specific screening for pre-diabetes 
in women to address their different experience of 
diabetes related diseases to that of men.
Recommendations 
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9. Peak bodies for NCDs use the Gender-responsive 
Assessment Scale (WHO 2010) to assess the extent 
to which their policies and programs recognise and 
integrate gender dimensions of NCDs, and then plan 
to redress the gaps highlighted by the application of 
the Scale. 
10. Key primary health organisations be identified to 
give priority to taking action:
•• on improving access to publicly funded 
(and therefore affordable) gender-sensitive 
chronic disease management services, and
•• for increasing women’s health literacy about 
NCDs through multilevel interventions 
targeted at individuals, organisations, 
general community and health practitioners. 
This includes prevention and health promotion 
programs to raise awareness of acute coronary 
disease differences in women.
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CVD: Cardiovascular disease are diseases of the heart 
(cardio) and blood vessels (vascular) and includes 
coronary heart disease (CHD heart attack and angina), 
stroke, and heart failure. 
DALYs: Disability Adjusted Life Years which is 
the sum of years of potential healthy life lost due to 
premature death and the years of productive life lost due 
to illness, injury or disability. This is the basis unit used 
in burden of disease or injury estimates.
Equity: the equally fair treatment of women and 
men, including recognition that women and men have 
different needs, preferences and interests and that 
equality of outcomes is dependent on recognition of 
the power differentials that operate in every society.
Gender: the economic, social and cultural attributes 
and opportunities ascribed to being female or male. 
Gender equity: The concept of gender equity 
recognises that men and women have different life 
experiences, different needs, different levels of power 
and access to decision-making in our society, differing 
expectations by others and different ways of expressing 
illness. Gender equity strategies recognise that gender 
leads to different opportunities for women and men 
(NSW Health 2000).
Gender health equity: Fair distribution of the social, 
economic and political determinants of health between 
women and men.
Incidence: the rate at which new cases of a condition 
occur in a population during a specified period.
Non-communicable diseases (NCDs): 
Non-communicable diseases, also known as chronic 
conditions/diseases, are a group of conditions including 
cardiovascular diseases, cancer, mental health problems, 
diabetes mellitus, chronic respiratory disease including 
asthma, chronic kidney disease, and musculoskeletal 
conditions. These disorders are largely preventable 
and are linked by common risk factors, underlying 
determinants, and opportunities for intervention. 
Most NCDs require long periods of care and treatment.
Definitions
Prevalence: the proportion of a population that 
is affected by a disease at a specific time, usually 
expressed as a percentage. 
Primary prevention: aims to prevent a disease or 
condition from occurring by taking proactive or 
prophylactic strategies to prevent health problems 
before they arise. 
Risk factors for NCDs: the four most common 
preventable risk factors for NCDs (for both women 
and men) are unhealthy diet, physical inactivity, tobacco 
smoking, and the harmful use of alcohol that lead to 
the key metabolic/physiological changes (raised blood 
pressure, overweight/obesity, raised blood glucose and 
raised cholesterol) (WHO 2014). 
Secondary prevention: aims to find, treat and manage 
disease early and to cure the disease if possible. 
Secondary prevention is focused on early diagnosis, 
appropriate referral, and rapid initiation of treatment 
to stop the progress of disease processes.
Social determinants of health: Social, economic, and 
political resources and structures that influence health 
outcomes including the material conditions of daily 
living: income, education, employment, gender, health 
care, culture, food security, social support and social 
exclusion and psychosocial dimensions of having control 
over one’s life and decisions that affect it. 
Social gradient: In general, the lower an individual’s 
socioeconomic position, the worse their health; the 
social gradient in health runs from top to bottom of 
the socioeconomic spectrum.
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Women are affected by non-communicable diseases 
(NCDs) in different ways to men. Not only are women’s 
experiences of NCDs influenced by the social conditions 
of women’s lives which are different to those of men, 
NCDs often manifest differently in women than they do 
in men. Moreover, women experience a higher burden 
from chronic disease and live more years of life with 
a disability from chronic disease then do men (AMA 
2014; AIHW 2012c). The purpose of this paper is to 
stimulate policy dialogue on the particular issues related 
to women and NCDs, to strengthen gender analysis in 
policy and programs, and strengthen the focus on gender 
in clinical guidelines and particularly, the equitable 
inclusion of gender analysis in research which is needed 
to inform guideline development. 
Women’s quality of life is affected by experiences and 
disadvantages that are distinctly gendered. Indeed, 
gendered stereotypes are embedded in health systems 
and care practices (NSW Health 2000) so research, 
policies and programs will be less effective if they 
assume a gender neutral position. Gender is an 
array of socially constructed roles and relationships, 
predispositions, attitudes, behaviours, values, relative 
power and influence that are socially ascribed to the 
two sexes on a differential basis. Gender is historically 
and culturally specific; it varies from society to 
society, and from time to time within a given society. 
Established gender norms and values in Australia mean 
that women typically have fewer resources than men 
(income, housing, employment) and have less power 
and influence. Equality for women means equal power 
in economic, political, health and educational spheres, 
while equity for women calls for recognition of their 
different needs in order to reach equality of outcomes.
The significance of gender equity and gender inequities 
for women’s health has been recognised internationally. 
Gender equity is a basic principle of the United Nations 
(UN) set out in the Preamble to the Charter of the 
United Nations; reaffirmed in the Convention on the 
Elimination of All Forms of Discrimination Against 
Women (CEDAW) in 1979. The Programme of Action 
of the International Conference on Population and 
Development (ICPD) in Cairo 1994 and the Beijing 
Platform for Action in 1995 recognise the significance 
of gender inequities for women’s health. This has been 
further noted in the outcomes of other major United 
Nations conferences including the World Conference 
on Human Rights in Vienna in 1993 and the World 
Summit for Social Development in Copenhagen in 
1995. In 1997, the United Nations Economic and 
Social Council (ECOSOC) adopted a resolution 
calling on all specialised agencies of the United 
Nations to mainstream a gender perspective into all 
their policies and programmes. Then from 2005-08, 
the WHO Commission on the Social Determinants 
of Health systematically examined the evidence and 
identified gender as both a determinant of health and a 
determinant of health inequities (WHO 2008, 2010).
Gender analysis requires assessment of distinctive 
patterns in the determinants of health and illness. 
Gender interacts with the social, economic and 
biological determinants as well as lifestyle risk factors 
for NCDs. Gender therefore, creates different health 
experiences and outcomes for males and females. That 
said, this paper will only briefly address the social 
determinants of women’s health which were covered in 
more detail in the AWHN Position Paper on Women 
and Health and Wellbeing (AWHN 2012a). 
Following the WHO (2011), the NCDs included in 
this paper are cardiovascular disease, chronic respiratory 
diseases, diabetes (Type 1 and Type 2), and some 
cancers. In addition, musculoskeletal disorders (MSDs) 
are included because they are a major cause of pain and 
mobility impairment. Mental health conditions are 
sometimes included in typologies of NCDs but will 
not be covered in this paper as they were addressed 
in the AWHN Women and Mental Health Position 
Paper (AWHN 2012c). This paper will review the 
incidence and prevalence of NCDs among women and 
factors related to gender that affect systems, health 
care practices and treatment choices. It will examine 
where a focus on gender could improve health outcomes 
in NCDs for women, and make resources available to 
women according to their needs (NSW Health 2000). 
Introduction 
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Impact of NCDs on women
NCDs are responsible for 70-80% of the total disease 
burden for Australians. Morbidity from NCDs is 
rising even though overall life expectancy is increasing. 
The ageing demographic, advances in health care and 
changes in how people live their lives are driving the 
rise of NCDs. Women represent a growing proportion 
of the ageing demographic and they experience a higher 
burden from NCDs. 
NCDs impact heavily on women’s lives because of 
social and cultural values about men’s experiences as 
the norm, therefore making women’s experiences less 
visible. This is very apparent in research as well as in 
the field of NCD prevention, treatment and long term 
management. NCDs also impact on society due to costs 
of healthcare and lost productivity. Although women, 
on average, live longer than men, they are in poor health 
for many of those years as a result of NCDs. Women’s 
lives are also impacted when NCDs cause illness in 
family members, because women frequently sacrifice 
paid work and therefore, personal income and financial 
security, to provide care for others.
Cancer, cardiovascular disease (CVD), diabetes and 
chronic respiratory diseases are the world’s leading 
causes of premature death in women and men, but 
importantly, are responsive to prevention and/or early 
detection (WHO 2010). Cancer causes the highest 
burden of all NCDs in terms of Disability Adjusted Life 
Years (DALYs) (Australian Government 2014). CVD 
is the biggest cause of premature death for women in 
Australia (AIHW 2010).
Breast cancer is the leading cancer among women 
with over 14,000 Australian women diagnosed each 
year. The five year survival rate is improving (currently 
about 89%), but about 2,700 women were expected 
to die from breast cancer in 2013 (AIHW 2012a). 
While survival rates continue to improve, Aboriginal 
and Torres Strait Islander women are less likely to be 
diagnosed in a timely manner (AIHW 2012b). 
Even though more women are diagnosed with breast 
cancer, lung cancer is more deadly. Smoking rates are 
declining in both men and women, and lung cancer 
mortality rates in men are starting to fall. However, 
mortality rates in women are continuing to rise 
because smoking rates peaked later among women 
than men (IARC 2013). Women who smoke have a 
significantly greater relative risk of lung cancer, that 
is, women may be more susceptible to the harms of 
smoking, although these effects may only be among 
heavy smokers (Huxley, Woodward 2011). 
Chronic respiratory conditions develop slowly among 
smokers, most of whom become addicted in adolescence. 
The increase in smoking-related diseases in women 
is resulting in increased death rates from lung cancer 
and chronic obstructive pulmonary disease (COPD) 
in women (McKenzie et al 2012). Respiratory disease, 
caused primarily by cigarette smoking, impairs quality 
of life and is a major risk factor for CVD. 
Other major causes of cancer death for women are 
gynaecological cancers (those pertaining to the women’s 
reproductive systems including cervical and ovarian 
cancer), and bowel cancer. GLOBOCAN 2012 
emphasises that globally, priority should be given to 
women’s cancer prevention, particularly screening and 
early detection for breast and cervical cancers (IARC 
2013). Even though Australia has nationally funded 
universally available screening programs for cervical and 
breast cancer, screening is not taken up by all women. 
In 2009-2010, the two-year participation rate for the 
National Cervical Screening Program was 57.4% of 
women in the target age group. The participation 
rate rises to 83.3% when measured over 3-5 years 
(AIHW 2012b). Breast screening programs achieved a 
participation rate of 55% in 2010-2011 (AIHW 2013). 
Screening rates are consistent with the social gradient 
– that is, women on lower rungs of the socio-economic 
ladder are less likely to participate in screening 
programs (AIHW 2012c). 
CVD is the biggest killer of women - four times as 
many women die of heart disease than breast cancer 
(Heart Foundation 2014), accounting for more than 
one-quarter of premature deaths among women 
(AIHW 2012b). Further, the absolute number of deaths 
due to CVD in women is likely to rise in proportion to 
the ageing population. Heart disease is considered to be 
premature when it occurs in men under 55 years and in 
women under 65 years (Heart Foundation 2012b). 
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Four per cent of Australians have diabetes, and three in 
five of those also have CVD. Overall, 120,000 people 
live with type 1 diabetes; 956,000 people live with 
type 2 diabetes; and 23,600 women develop gestational 
diabetes mellitus (GDM). ‘For every person diagnosed 
with diabetes there is usually a family member or carer 
who also ‘lives with diabetes’ every day in a support role. 
This means that an estimated 2.2 million Australians 
are affected by diabetes every day’ (Diabetes Australia 
2013). Given that 60-70% (depending on the measure) 
of primary carers are women (Commonwealth Financial 
Planning 2009), it is therefore, women who carry a 
disproportionate financial and social burden from 
diabetes and undoubtedly, other NCDs. 
Diabetes in pregnancy, including pre-existing diabetes 
and GDM, affects 1 in 20 pregnancies (AIHW 2014). 
GDM impacts on both the mother and the child, 
potentially predisposing that child to CVD conditions 
in later life. Indigenous women have higher rates of 
gestational diabetes than non-Indigenous women. The 
prevalence of diabetes is increasing among older women 
due to women’s longer life expectancy, and there are also 
increasing numbers of young women developing type 2 
diabetes (Better Health Channel 2014). 
It has been known for some years that diabetes increases 
the risk of heart disease among women to a greater 
extent than it does for men (Barrett-O’Connor 2007). 
The evidence is also now convincing that women with 
diabetes have a higher risk of stroke than their male 
counterparts, confirming previous findings that women 
with diabetes have poorer survival after stroke than men 
(Peters, Huxley and Woodward 2014). The causes of 
the sex difference require further research in order to 
improve medical care for women with diabetes but the 
knowledge about women’s risk can and should be built 
into guidelines immediately. 
The most prevalent musculoskeletal disorders are back 
problems, osteoarthritis, osteoporosis and rheumatoid 
arthritis (Arthritis and Osteoporosis 2013). Both 
osteoarthritis and rheumatoid arthritis are more 
prevalent among women, with 19.9% of women 
estimated to have some form of arthritis in 2007 
compared to 17.1% of men (Arthritis Australia 2007). 
Musculoskeletal disorders, such as osteoarthritis are not 
considered to be preventable while osteoporosis is largely 
preventable. There is a relationship between some 
musculoskeletal conditions and obesity and osteoporosis, 
which in turn, are related to nutrition and physical 
activity levels (NPHP 2001). Musculoskeletal disorders 
affect more than a quarter of the population, and 
frequently present as co-morbidities with depression and 
with vascular conditions in older people (NPHP 2001). 
The chronic pain and impairment of mobility associated 
with MSD impact on women’s quality of life and risk 
of falling and consequent risk of fractures. Women in 
the Australian Longitudinal Study on Women’s Health 
who reported arthritis had higher health care use and 
higher Medicare costs in general, with Medicare costs 
for women with arthritis 31% higher than for those 
without arthritis (Parkinson, Curryer, Gibberd et al 
2013). This means that women are likely to be bearing 
a high financial impact from treating and managing 
their arthritis condition with out-of-pocket costs, 
prescriptions and over-the-counter medications.
Women and non-CommuniCable diseases12
Many NCDs are linked to common risk factors of 
tobacco use, harmful use of alcohol, unhealthy diet, 
physical inactivity, environmental carcinogens and 
low health literacy (AWHN 2012a). All risk factors 
are highest among the most disadvantaged groups in 
Australian society. Chronic disease in adulthood is 
associated with risk exposures across the life course 
(NPHP 2001). For women, these risk exposures include 
during pregnancy, and for women with low socio-
economic status (AWHN 2012a). In other words, 
good nutrition and physical activity are protective 
factors for healthy ageing, as is sufficient income and 
social support. Conversely, overweight and obesity are 
strongly associated with prevalence and incidence of 
hypertension, heart disease, diabetes, asthma and the 
prevalence of arthritis, whilst low levels of education 
are associated with greater risks of chronic disease in 
later life (ALSWH 2006). Among women, low levels 
of education are associated with higher prevalence 
of hypertension, obesity and arthritis, and with 
prevalence and incidence of diabetes and osteoporosis 
(ALSWH 2006).
Risk factors are considered to be modifiable and from 
a gender equity perspective, there is good evidence 
that gender-specific prevention and health promotion 
programs improve outcomes for women. NCD 
interventions need to be developed for women separately 
from men, along with efforts to understand the 
challenges of lifestyle modification for disadvantaged 
women (NSW Health 2000; Cleland et al 2013). 
Hypertension (high blood pressure) and high body mass 
are the two biggest contributors to the total burden 
of disease among women. Hypertension accounts for 
42% of the CVD burden for women although the 
burden is less for females than males (AIHW 2010). 
Pregnancy, pre-eclampsia, gestational diabetes, use of 
oral contraceptives and use of hormone treatments are 
associated with increased risk of stroke (Roeters et al 
2002; Peters et al 2014).
Diabetes is a powerful risk factor for CVD and smoking 
is a powerful risk for complications in people with 
diabetes. Both diabetes and tobacco have an inverse 
relationship with levels of education (ANPHA 2013). 
Women who are overweight or obese have increased 
risk of gestational diabetes with greater risk for 
the child of Type 2 diabetes and CVD in adult life 
(NCD Alliance 2011). 
The harmful effects of smoking are higher for women 
than for men. Women who smoke have a 25% increased 
risk for CVD independent of all other CVD risk factors, 
despite the mean consumption of cigarettes per day 
being lower for women than men. COPD occurs at 
lower levels of exposure to tobacco smoking in women 
than men, resulting in earlier development of respiratory 
disease (Huxley, Woodward 2011). 
Preventable risk factors for musculoskeletal disorders 
(MSD) are much less clear, there is research about 
work-related musculoskeletal injuries to the neck and 
lower back from movement, repetitive work and posture 
(DHHS 1997). Other than workplace related MSDs, 
the common behavioural risk factors for other NCDs 
are also common to MSDs (Australian Government 
2014). Women in the mid-life and older cohorts of the 
Australian Longitudinal Study on Women’s Health 
found that women with MSDs are high users of medical 
services (Dobson 2003). 
Poverty and the social gradient are also risk factors for 
NCDs. In other words, socio-economic position and 
material circumstances lead to the unequal distribution 
of health and well-being. The determinants of social 
position include education, occupation, income, gender 
and ethnicity. The fundamental structures of society 
determine the conditions that result in good health, ill 
health or disease, and in which people grow, live, work 
and age. It is the differential exposure to, and experience 
of, those conditions of living (such as education, 
employment and secure/adequate housing) that create 
health inequities (WHO 2008; UNDP 2013). 
Further, gender norms and roles create inequitable 
power relations between men and women that affect 
women’s vulnerability and exposure to health risks, 
their health-seeking behaviour and eventual health 
outcomes (WHO 2010). For example, strong socio-
cultural expectations of women to conform to norms 
of duty and responsibility to others before themselves 
can produce behaviours that demonstrate a desire 
Risk factors and Social Determinants of NCDs
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to please others. Such norms result in behaviours 
associated with passivity, dependence, unassertiveness 
and low self-esteem, which in turn, affects women’s 
self-care. Women also frequently carry a heavy burden 
for domestic work and child-rearing while also in paid 
employment, which also affects their self-care. Gender 
and cultural norms influence health seeking behaviours 
and decision making, whilst low incomes influence 
access to the resources needed for effective self-care. 
Women particularly in need of support to adopt health-
seeking behaviours include Aboriginal and Torres Strait 
Islander women, women born overseas in non-English 
speaking countries, women with disabilities, GLBTQI 
women and older women. In addition, systemic 
upstream barriers that influence health-behaviours 
including insecure housing, sexual discrimination and 
poverty also need to be addressed. Women who are 
more vulnerable to poor health behaviours require a 
more equitable allocation of resources than women and 
men with higher levels of advantage.
NCDs are strongly related to the social gradient, and 
this is apparent in mortality rates and in women and 
men’s experiences of living with a long-term health 
condition (NATSEM 2012). Many people on low 
incomes experience increased exposure to common 
modifiable risk factors which are underpinned by 
the social conditions of their lives. Disadvantaged 
people, among whom women are over-represented, are 
generally low income earners, and lack the essentials 
for a decent life including nutritious food, affordable 
housing, transport and capacity to pay health care costs. 
Poverty and NCDs continually reinforce one another 
to create circumstances that increase inequalities 
(Beaglehole , Bonita, Horton et al 2011). Women who 
also live with an NCD while being a primary carer and/
or living on a low income are in added jeopardy of being 
unable to afford the healthcare costs associated with 
managing a chronic NCD or contribute to household 
income because of poor health. For example, women 
experiencing socioeconomic disadvantage are at high 
risk of inactivity (Cleland et al 2013). Neighbourhood 
characteristics, social characteristics and cognitive 
characteristics impact on resilience to risk factors 
(Cleland et al 2013). 
Not only are the most socio-economically disadvantaged 
more likely to have an NCD, they die on average three 
years earlier than more affluent people with the same/
similar condition. In addition, people who are socio-
economically disadvantaged and have an NCD have 
lower overall wellbeing and reduced likelihood that 
they can gain income from paid work, so their reliance 
on Government income support and their use of health 
services is higher (NATSEM 2012). The consequent 
losses to productivity result in reduced economic output 
for any society (Beaglehole, Bonita, Horton et al 2011).
Finally, low health literacy is regarded as a primary 
risk factor for NCDs. Health literacy is increasingly 
recognised as a key determinant of health with rates 
of low health literacy in Australia no different to 
other developed countries (ABS 2009). Lower health 
literacy is independently associated with higher rates 
of morbidity and mortality, poorer health knowledge, 
greater medication errors and higher hospitalisation 
rates in general. Low health literacy is more common 
among socially disadvantaged groups, which are 
the same populations experiencing higher rates of 
preventable non-communicable diseases, and greater 
difficulties accessing health services and managing 
their health conditions (WUN nd).
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Access to timely health care is a social determinant 
of health. If the disease patterns for women are seen 
as outside the ‘norm’ and yet the burden for women is 
certainly no less than it is for men, then there needs 
to be change in attitudes towards both women and 
NCDs. It is well established that women experience the 
symptoms of acute coronary disease differently to men 
–that is, women commonly report pain that is referred 
to as ‘atypical’ – yet for women, it is likely to be the 
norm. That pain can be sharp and pleuritic, often with 
neck, jaw, back or epigastric discomfort or dyspnoea, 
nausea and vomiting, rather than the crushing central 
chest pain which is considered ‘typical’ of episodes of 
CVD pain which is the type of pain experienced by 
men (McSweeney et al., 2003; Aroney et al 2006). 
The language of typical and atypical cardiovascular 
symptoms indicates that men’s symptoms of acute 
coronary disease are the norm, and this is apparent in 
current CVD guidelines (Heart Foundation 2014). 
Information about other NCDs is also largely gender 
neutral (see below).
Because of women’s apparently different symptom 
patterns, clinicians who are unaware of the gender 
differences in presentation may misdiagnose women 
when they present with acute coronary disease 
(Worrall-Carter et al 2011). Although not inclusive of 
Australian studies (which suggests that such studies 
do not exist), a meta-analysis showed that women also 
receive fewer specialist diagnostic procedures (Giralt 
et al., 2011) with gender differences also in therapeutic 
management of ischaemic stroke. Other studies have 
found that women are less likely to receive optimal 
guideline-based treatment (Ciambrone & Kaski, 
2011; Giralt et al., 2011). Women are more likely 
to experience poor outcomes, including death, after 
a cardiovascular event (Pepine, 2004; Reeves et al., 
2008). Common cardiovascular drugs are generally 
less effective in women than in men though the specific 
biological mechanisms are still being researched 
(McMullen 2014). 
Access to affordable health care is also a social 
determinant of health. Although Australia’s health 
system is founded on universal health insurance, the 
system does not guarantee affordable, accessible or 
timely health care. Out-of-pocket costs in the primary 
health care sector are a barrier to access and equity 
and getting the right treatment. AWHN (2012b) has 
previously noted that women have higher annual health 
care expenses due to their higher use of medical services 
throughout their lives and their responsibilities for the 
health of others. Further, women are over-represented 
in the two lowest-income quartiles and head 87% of 
lone-parent families. Women’s care of children and 
older family members not only increases the demands 
on their incomes, it also reduces their time available for 
paid work. 
Women who live in rural and remote areas of Australia 
have significantly poorer access than urban women to 
healthcare, and are less likely than urban women to 
visit doctors/general practitioners frequently or to see 
specialists. Access to doctors who bulk bill is lower for 
country women and their out-of-pocket costs are higher 
(Dobson 2003). 
NATSEM (2012) has made the case that timely care 
of socio-economically disadvantaged Australians with 
a chronic disease would not only diminish the social 
gradient in health, but would save billions of dollars 
annually, improve overall health outcomes, and lead to 
major social and economic gains. Savings to both the 
Government and to individuals would result from lower 
hospital costs, reduced Pharmaceutical Benefits Scheme 
prescriptions, welfare support payments, and fewer 
Medicare services each year. 
Access to care
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The evidence is now strong for the mainstreaming of 
gender in policy, programs, and research. AWHN has 
previously argued (AWHN 2012a) to improve outcomes 
for women, it is necessary to mainstream gender 
through gender analysis, gender sensitive research, and 
the inclusion of gender equity goals in policies, projects 
and institutional ways of working. Mainstreaming 
gender requires high-level commitment, governance 
mechanisms, and robust structures for monitoring, 
evaluation and accountability. 
Gender intersects with health systems which comprise 
policy-makers in government departments, NGOs 
including health foundations and the wider system of 
care providers. Health sector leadership is an anchor 
for gender-specific responses that support gender 
equity. Yet, generally there is a lack of responsiveness in 
Australia to the issues for health raised by knowledge 
about gender as a social determinant of health and 
health inequities. Data on mortality and morbidity and 
women’s experiences of NCDs provide the evidence 
base for research into gender differences in treatment, 
and primary prevention. This is a key policy issue that 
requires stronger policy responses than Australia has 
seen to date (Keleher 2013).
Mainstreaming gender into NCD work
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Gender based analysis
Gender based analysis indicates where effective action can be taken. Analysis has shown that Australian health 
policies are largely gender neutral and lack a social determinants view of health (Keleher 2013). Australian and 
global literature is replete with recommendations for lifestyle interventions (eg Global Advocacy for Physical Activity 
2014) without recognising the barriers to lifestyle change that arise from the gendered social determinants of health 
(see AWHN 2012a). With the exception of specific women’s health policies Australia’s health policies show a form 
of stereotyping that limits women’s primary role to reproductive issues with a distinct lack of gender perspective or 
gender equity considerations (Keleher 2013; Keeling 2011).
Tools are available to assess the extent to which policies and programs recognise and integrate gender, and these are 
easily applied to gauge policy and program capability with regard to gender dimensions of NCDs (Keleher 2013; 
WHO 2010). One useful , easy-to-use tool is from the WHO (2010), which comprises five criteria for assessing 
the gender-responsiveness of policy and programs (Box 1).
box 1: Gender-responsive assessment scale criteria: a tool for assessing programmes and policies
Level 1: Gender unequal
		Perpetuates gender inequality by reinforcing 
unbalanced norms, roles and relations
		Privileges men over women (or vice versa)
		Often leads to one sex enjoying more rights 
or opportunities than the other
Level 2: Gender blind
		Ignores gender norms, roles and relations
		Very often reinforces gender-based 
discrimination
		 Ignores differences in opportunities and 
resource allocation for women and men
		Often constructed based on the principle of 
being ‘fair’ by treating everyone the same
Level 3: Gender sensitive
		Considers gender norms, roles and relations
		Does not address inequality generated by 
unequal norms, roles or relations
		Indicates gender awareness, although often 
no remedial action is developed
Level 4: Gender specific
		Acknowledges different norms and roles for women 
and men and how they affect access to and control 
over resources
		Considers women’s and men’s specific needs
		Intentionally targets and benefits a specific group 
of women or men to achieve certain policy or 
programme goals or meet certain needs
		Makes it easier for women and men to fulfil duties 
that are ascribed to them based on their gender roles
		Does not address the underlying causes of 
gender differences
Level 5: Gender transformative
		Acknowledges differences in the norms and roles for 
women and men and that these affect access to and 
control over resources
		Considers women’s and men’s specific needs
		Addresses the causes of gender-based health inequity
		Includes ways to transform harmful gender norms, 
roles and relations
		The objective is often to promote gender equality
		Includes strategies to foster progressive changes in 
power relationships between women and men
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The under-representation of women in clinical trials has 
been well documented (Holdcroft 2007; Ballantyne, 
Rogers 2008, 2011). The fair representation of women 
and appropriate inclusion of women and gender 
analysis in medical research is necessary to develop 
the evidence that will lead to improved health care for 
women, and to inform clinical guidelines. Despite some 
advances toward greater inclusion, women are not 
being included in clinical trials in sufficient numbers 
proportionate with the disease burden and prevalence 
in the population. 
Cardiovascular trials show that just 30% of participants 
are women, while only one-third of trials report sex-
disaggregated findings. Treatment recommendations 
are therefore more generalisable for males than females 
(Worrall-Carter et al 2011) and the research benefits are 
therefore greater for men because the population is not 
homogenous. Indeed, trials may be excluding the people 
most at risk and this exclusion accords a lower status to 
women’s health (Holdcroft 2007: 3). The effect of drugs 
(side effects and efficacy) to treat CVD in women has 
therefore not been adequately researched because of the 
bias towards men in trials. If trials are not designed to 
measure gender differences (ie, they are gender blind), 
then they promote gender inequity. To date, there is 
a lack of adequate gender sensitivity in both research 
and guidelines. 
In addition to clinical trials for treatments, gender 
sensitive prevention and health promotion programs 
would improve health literacy about NCDs among 
women. Well-designed trials are needed to understand 
what works in raising awareness of women’s risks for 
and vulnerabilities to NCDs and women’s symptom 
patterns. Without equal representation of women in 
research trials, there is likely also to be a gap in the 
translation of research knowledge into guidelines.
Gender sensitive research
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Research has shown that Australia’s health policies 
are remarkably gender neutral (Keleher 2013), 
demonstrating that progress towards gender equity 
mainstreaming is not sufficiently guiding research and 
evidence-building in guidelines for management of 
NCDS. The concepts of sex and gender are not applied 
appropriately in guidelines. With the exception of the 
Lung Foundation guidelines on COPD, the guidelines 
include sex differences in prevalence and incidence, 
but not gender specific information. 
Peak bodies in Australia have key roles in the 
development of guidelines and are funded by the 
Australian government to undertake this work. 
There are peak bodies for all of the NCDs discussed 
in this position paper. They are engaged in a mix of 
fund-raising, advocacy, lobbying, research, community 
and health professional education and the production 
and dissemination of health information, though their 
size and capacity varies quite widely. That said, these 
organisations have leadership roles in the generation of 
information that is gender aware, and gender specific.
In organising the first Australian forum on women 
and heart disease, the Heart Foundation (2011) has 
made recommendations for advancing knowledge and 
strengthening systems in relation to gender differences 
in heart disease. The Heart Foundation provides 
specific information on its website about the nature of 
heart attacks in women. Nonetheless, the guidelines 
for management of acute coronary syndromes are 
gender neutral apart from noting that women may have 
‘atypical’ symptoms. It is time that CVD guidelines are 
updated to reflect the evidence that is now established 
on gender differences and the implications for gender 
specific treatment.
Diabetes Australia’s website does not yet carry any 
gender specific information. Diabetes Australia is 
campaigning for a new National Diabetes Strategy 
to which the Coalition government has committed. 
This provides a not-to-be-missed opportunity to address 
gender-specific information based on the evidence 
available, to ensure that the distinct needs of women 
and men with diabetes are recognised and incorporated 
into primary prevention, health promotion and 
treatment/care guidelines. 
Gender in NCD Guidelines
Cancer Councils websites produce detailed information 
by sex on prevalence and incidence as well as risk but 
limited information on gender. Similarly, Arthritis 
Australia has developed reports and health information 
but apart from indicating that certain types of arthritis 
are more common in women, there is little by way of 
gender analysis.
Tobacco cessation programs are improving the gender 
sensitivity of programs though is much work to be 
done (Greaves et al 2006). QUIT Victoria’s website 
demonstrates better gender awareness than the sites 
in other states.
Guidelines for the management of COPD are managed 
by the Lung Foundation Australia and The Thoracic 
Society of Australia and New Zealand as part of 
a national COPD program. The sex and gender 
differences in COPD prevalence, symptoms, diagnosis 
and determinants of COPD (Pederson, Hoyak et al 
2007) have been incorporated into the Australian 
guidelines on COPD (McKenzie et al 2012) which 
can be regarded as gender-sensitive and equitable.
In summary, most NCD peak bodies are not yet 
sufficiently gender sensitive or inclusive of women. 
Most guidelines are gender blind. By not demonstrating 
awareness of women specific issues in NCDs, those 
guidelines and their peak bodies are promoting gender 
inequity. The lack of data from trials about women 
leads to assumptions in treatment that may or may not 
be correct. Further, this lack of gender-based evidence 
may be the reason why cardiovascular disease outcomes 
in women are not improving at the same rate as for men 
(Pilote 2007).
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Addressing the gender dimensions of NCDs is essential 
to constructing effective and sustainable strategies 
that will ameliorate the negative impacts of NCDs 
on women’s lives. For that to occur, there are levels 
of change needed:
•• gender sensitive policy is essential to provide 
leadership for the integration of gender into all levels 
of research, strategy and action
•• research policy to guide gender sensitive research is 
vital to inform treatment and prevention guidelines
•• guidelines are rewritten to incorporate the most 
recent evidence about gender differences into 
clinical practice. 
This paper challenges the gender neutral approaches 
taken in policy, research and clinical guidelines. 
The time for gender-transformative approaches has 
come. They are necessary to achieve gender equity 
and ensure that women’s experience of NCDs is 
transformed. 
Conclusion
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